Navigation Links
Hundreds dying in northeast from AIDS

A large number of people in India's northeast living with HIV, the virus that causes AIDS, are struggling for survival. Hundreds are dying// with no access to treatment.

"People are dying regularly and suffering a lot, unable to access Anti Retroviral Therapy (ART) because such medicines are very expensive," said Dipak Singh, president of the Manipur Network of Positive People (MNPP).

Two MNPP members died earlier this week allegedly due to lack of medication. "Hundreds have died with no access to treatment," Singh told IANS.

Although it is not a cure, ART is a combination of medicines that helps a person living with HIV to fight off infections and live a longer life.

Besides, ART also significantly impacts transmission by reducing the viral load concentration and minimising risk of transmission to their sexual partners.

A person living with HIV requires drugs worth about Rs.1,200-1,600 a month and the cost doubles if someone has to go for second line therapies depending on the nature of their immune system.

India accounts for about 5.2 million HIV-positive people, second only to South Africa. The northeast has been declared as one of the country's high-risk zones with close to 100,000 people infected with the virus.

The National AIDS Control Organisatrion (NACO), India's apex government agency to combat HIV/AIDS, admitted in a recent report that non-availability of adequate ART in the northeast was a matter of concern.

"Lack of availability of ART and lack of research keeping in line with issues relevant to the epidemic were identified as gaps in the programme (for preventing the spread of HIV)," said a recent NACO, AusAID, and UNAIDS study titled "Rapid Needs Assessment of HIV Programme Needs in Five Northeastern States of India".

"The demand for ART is bound to be high and needs to be addressed."

There are no official estimates or studies done t o ascertain the number of HIV-positive people not having access to treatment.

"In Manipur we provide free ART through our roll out centres to about 2,500 people although the number of HIV-positive people in the state is nearly 23,000," said Promod Kumar Singh, head of Manipur government's AIDS Control Society.

Manipur lies on the edge of the heroin-producing "Golden Triangle" of Laos, Myanmar and Thailand and independent estimates have put the number of regular injecting drug users in the state at close to 200,000 - a key cause of HIV infection here.

"The problem is further compounded with HIV positive people now showing opportunistic infection like Hepatitis C. For such people treatment is very expensive. There is no access to treatment for thousands of such people in the northeast due to the cost factor," said S.I. Ahmed, chairman of the AIDS Prevention Society, a community healthcare group in Assam.

"I don't think I am going to survive beyond three to five years as I am co-infected with Hepatitis C. I am taking ART regularly but I cannot afford to take medicines for Hepatitis C," the MNPP president said.

The scenario is similar in most of the northeastern states. "The economic condition of the people in the northeast living with HIV is so poor that many of them cannot even afford to come to the ART roll out centres located in the towns or district headquarters to collect the free medicines," said C. Anand, coordinator on HIV/AIDS of the Catholic Relief Services, another community healthcare group in Assam.

A top UN official on HIV/AIDS said inadequate access to treatment could further aggravate the epidemic in the northeast.

"The response to the epidemic is to have proper access to treatment," said Noble Thalari, senior communication advisor of UNAIDS in India.


Related medicine news :

1. Man Arrested For Sending Hundreds Of Anthrax Hoax Letters
2. Hundreds Of Jobs To Be Lost With The Merger Of Two Major Hospitals In UK
3. Hundreds of human tissue products been recalled
4. Burning fires in Northern Ontario Cause Hundreds to leave their Homes
5. Hundreds of Children Put on a Trial to Trace the Cause of Peanut Allergy
6. Hundreds Literally Sea ‘sick’ on Luxury Linr
7. Hundreds of Turkeys Die Due to Bird Flu
8. Patients with testicular cancer dying through unfamiliarity
9. Studying The Causes Of Autism
10. Studying The Effectiveness Of Cough Syrups
11. Patients with long ICU stay may be at risk from dying
Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: